Q BioMed Inc. Provides Update to Shareholders

PR NewswireJun 23, 2023 08:00 ET

Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Patent From United States Patent Office and Notice of Allowance for Europe

PR NewswireApr 14, 2023 08:06 ET

Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Up 24.6% in February

kopsourceMar 4, 2023 11:42 ET

Q BioMed Chemotherapy Uttroside B for Liver Cancer to Get US Patent

Seeking AlphaFeb 10, 2023 08:39 ET

Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent From United States Patent Office

PR NewswireFeb 10, 2023 08:05 ET

Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Expands By 21.2%

Defense WorldJan 22, 2023 03:51 ET